scanX
Home
Dabur

Dabur

460.00
-8.70
(-1.86%)
search
Market Cap
81,526.64 Cr
EPS
10.40
PE Ratio
47.07
Dividend Yield
1.70 %
52 Week High
672.00
52 Week Low
433.30
PB Ratio
7.70
Debt to Equity
0.13
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from38 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+44.74 %
+44.74 %
Hold
Hold+39.47 %
+39.47 %
Sell
Sell+15.79 %
+15.79 %

Company News

View All News
Caret
negative
Dabur India: Shares Fall on Weak Q4 Results, Analyst Downgrades1 day ago
Dabur India's shares dropped nearly 4% after Q4 results showed flat revenue and declining profits. Domestic volume contracted 3%. Multiple analysts downgraded the stock or cut price targets due to weak performance across segments and low EBITDA margins. Management expects gradual recovery and margin expansion in FY26.
negative
Dabur India: Q4 Profit Falls 8.4%, Shares Decline Post-Results1 day ago
Dabur India reported a consolidated net profit of ₹320.13 crore for Q4FY25, down 8.4% YoY. Revenue increased marginally by 0.5% to ₹2,830 crore. EBITDA declined 8.6% to ₹426.8 crore with margin compression. The company declared a final dividend of ₹5.25 per share. Dabur shares fell over 4% in early trade following the results announcement.
neutral
Dabur India: Dolat Capital Upgrades to 'Buy' Despite Mixed Q4 Results1 day ago
Dabur India's Q4 results show mixed performance across segments. Dolat Capital upgrades the stock to 'Buy' but lowers target price due to varied segment growth. Skin care grew 8%, while hair care and oral care declined. Healthcare and food segments also saw declines, except for foods and Badshah brands.
View more

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Godrej Consumer Products
1,227.30
#1 1,25,553.77
66.91
#1 14,365.10
6.53
-561
#1 121.76
59.02
Dabur
460.00
#2 81,526.64
#4 47.07
#2 12,886.40
#5 7.61
#1 1,811
#9 -8.35
39.35
Colgate Palmolive
2,501.20
68,029.05
47.40
5,757.00
9.04
1,324
-2.21
48.87
P&G Hygiene and Health Care
13,721.00
44,539.38
63.69
4,258.00
7.57
675
17.34
50.07
Emami
619.30
27,032.44
34.08
3,624.90
4.32
724
7.06
53.06
Gillette
7,715.50
25,141.12
54.23
2,659.20
6.40
412
21.27
44.46
Mamaearth
244.00
7,934.48
102.88
1,969.60
#1 29.98
111
0.39
59.26
Bajaj Consumer Care
163.18
2,236.43
#1 18.99
1,028.80
3.10
155
-12.92
47.15
Cupid
82.67
2,218.49
42.09
178.30
8.65
40
23.60
73.94
Radix Industries
174.50
261.85
100.81
33.10
25.86
2
42.86
47.24
Growth Rate
Revenue Growth
7.61 %
Net Income Growth
6.47 %
Cash Flow Change
35.27 %
ROE
-2.44 %
ROCE
-3.02 %
EBITDA Margin (Avg.)
2.66 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
1,990
1,949
2,011
2,027
2,064
2,013
2,071
1,936
1,980
1,872
2,043
2,033
2,106
2,155
2,206
2,275
2,194
2,347
2,294
2,427
1,941
2,052
2,604
2,810
2,422
2,696
2,930
3,039
2,617
2,923
3,110
3,144
2,799
3,240
3,321
3,382
2,944
3,479
3,180
3,484
2,971
Expenses
1,604
1,586
1,555
1,594
1,595
1,603
1,573
1,519
1,497
1,496
1,539
1,563
1,548
1,695
1,674
1,754
1,746
1,836
1,762
1,880
1,534
1,563
1,947
2,155
1,895
2,060
2,197
2,314
2,150
2,279
2,386
2,434
2,268
2,526
2,543
2,588
2,348
2,694
2,476
2,673
2,403
EBITDA
385
363
456
433
469
410
498
417
483
376
504
470
558
460
532
521
448
511
532
547
408
488
657
655
527
637
733
724
467
644
724
710
530
714
778
795
595
784
704
810
568
Operating Profit %
18 %
17 %
20 %
19 %
21 %
18 %
21 %
18 %
22 %
16 %
21 %
21 %
24 %
19 %
21 %
20 %
18 %
19 %
20 %
20 %
18 %
21 %
23 %
21 %
19 %
21 %
22 %
21 %
15 %
19 %
20 %
20 %
15 %
19 %
21 %
21 %
17 %
20 %
18 %
20 %
15 %
Depreciation
28
33
33
32
36
34
36
33
40
39
40
41
43
43
43
45
46
53
55
54
59
57
60
57
67
61
63
63
65
68
71
71
102
97
98
97
107
109
111
109
117
Interest
10
12
13
11
13
12
17
14
12
13
13
13
13
15
16
17
12
15
15
11
9
8
8
7
9
8
8
11
12
12
15
19
32
24
28
37
35
33
47
44
39
Profit Before Tax
352
324
415
395
420
364
446
370
431
324
451
416
502
402
474
460
389
443
462
482
340
424
590
591
452
568
661
650
390
564
638
620
396
593
651
661
453
643
546
658
412
Tax
67
62
75
77
87
70
87
75
98
59
88
83
105
72
96
92
18
79
58
84
59
83
107
98
74
130
156
146
95
123
147
144
104
137
144
155
111
148
128
142
99
Net Profit
285
263
340
318
333
294
358
295
334
265
363
333
397
330
378
367
372
364
404
399
282
341
483
494
377
438
505
504
294
441
491
477
293
457
507
506
341
494
418
516
313
EPS in ₹
1.62
1.49
1.94
1.81
1.88
1.66
2.03
1.67
1.89
1.50
2.05
1.89
2.25
1.87
2.13
2.07
2.10
2.06
2.28
2.25
1.59
1.93
2.73
2.78
2.14
2.47
2.85
2.85
1.66
2.49
2.77
2.69
1.70
2.62
2.91
2.90
1.97
2.82
2.40
2.95
1.81
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
6,106
6,932
7,732
8,702
8,437
9,354
10,847
12,285
13,654
15,123
Fixed Assets
1,877
1,728
1,958
2,028
1,969
2,253
2,243
2,308
3,579
3,815
Current Assets
2,731
3,216
3,115
3,440
3,586
4,880
4,776
4,317
4,249
5,680
Capital Work in Progress
50
45
42
42
64
147
147
168
175
232
Investments
406
2,630
3,240
3,805
3,359
2,800
4,160
6,220
6,265
6,933
Other Assets
3,773
2,529
2,492
2,827
3,045
4,155
4,297
3,590
3,635
4,143
Total Liabilities
6,106
6,932
7,732
8,702
8,437
9,354
10,847
12,285
13,654
15,123
Current Liabilities
2,419
2,254
2,225
2,434
2,660
2,464
2,934
3,323
3,609
3,930
Non Current Liabilities
316
487
636
534
113
248
213
540
604
889
Total Equity
3,372
4,192
4,872
5,733
5,663
6,642
7,700
8,422
9,441
10,303
Reserve & Surplus
3,179
3,995
4,671
5,530
5,455
6,429
7,487
8,205
8,796
9,689
Share Capital
176
176
176
176
177
177
177
177
177
177
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-246
82
81
-27
-52
54
97
38
-130
-119
Investing Activities
-876
-730
-807
-541
338
-517
-1,404
-1,273
-583
-971
Operating Activities
1,047
1,187
1,227
1,092
1,499
1,614
2,115
1,802
1,488
2,014
Financing Activities
-417
-374
-339
-577
-1,888
-1,043
-613
-491
-1,035
-1,161
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
67.38 %
67.36 %
67.36 %
67.37 %
67.38 %
67.24 %
67.24 %
66.24 %
66.24 %
66.23 %
66.23 %
66.24 %
66.25 %
66.24 %
66.25 %
66.26 %
66.27 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
15.83 %
14.98 %
15.04 %
13.27 %
12.68 %
DIIs
5.28 %
4.61 %
3.36 %
3.51 %
3.78 %
3.98 %
5.77 %
7.61 %
8.43 %
8.87 %
8.61 %
10.35 %
12.56 %
13.56 %
13.67 %
14.92 %
15.69 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
5.43 %
5.29 %
5.28 %
5.55 %
5.28 %
5.18 %
4.47 %
4.34 %
4.32 %
4.29 %
4.26 %
4.28 %
4.19 %
4.03 %
3.92 %
4.34 %
4.19 %
Others
21.91 %
22.74 %
23.99 %
23.57 %
23.56 %
23.61 %
22.53 %
21.82 %
21.00 %
20.61 %
20.90 %
19.13 %
1.17 %
1.18 %
1.12 %
1.20 %
1.17 %
No of Share Holders
2,96,439
3,18,852
3,59,529
4,33,443
4,82,133
4,83,560
4,57,490
4,43,618
4,48,975
4,44,832
4,33,501
4,39,123
4,34,823
4,35,213
4,30,436
5,10,298
5,05,557

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 2.25 7.5 2.75 3 4.75 5.2 5.2 5.5 0.00
Dividend Yield (%) 0.00 0.69 1.83 0.61 0.56 0.89 0.97 0.99 1.09 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
07 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 07 Aug 2025 480.60 468.70
07 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 07 May 2025 512.65 480.60
30 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 30 Jan 2025 504.00 518.15
08 Nov 2024 DIVIDEND Dividend
₹ 2.75 /share
 08 Nov 2024 535.85 534.30
30 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 30 Oct 2024 661.00 535.85
08 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 08 Aug 2024 599.10 639.40
22 Jul 2024 DIVIDEND Dividend
₹ 2.75 /share
 19 Jul 2024 507.55 632.90
10 Nov 2023 DIVIDEND Dividend
₹ 2.75 /share
 10 Nov 2023 517.15 535.80
24 Jul 2023 DIVIDEND Dividend
₹ 2.70 /share
 21 Jul 2023 537.95 565.20
04 Nov 2022 DIVIDEND Dividend
₹ 2.50 /share
 03 Nov 2022 532.15 555.90
25 Jul 2022 DIVIDEND Dividend
₹ 2.70 /share
 21 Jul 2022 538.05 576.10
12 Nov 2021 DIVIDEND Dividend
₹ 2.50 /share
 11 Nov 2021 597.05 596.80
02 Aug 2021 DIVIDEND Dividend
₹ 3.00 /share
 29 Jul 2021 545.25 600.50

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication22 hours ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome1 day ago
Announcement under Regulation 30 (LODR)-Change in Directorate1 day ago
Submission Of Code Of Practices And Procedures For Fair Disclosure Of UPSI1 day ago
Corporate Action-Board approves Dividend1 day ago
Announcement under Regulation 30 (LODR)-Change in Management1 day ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release1 day ago
Announcement under Regulation 30 (LODR)-Investor Presentation1 day ago
Audited Financial And Segment Wise Results For The Quarter And Year Ended March 31 20251 day ago
Board Meeting Outcome for Audited Financial And Segment Wise Results For The Quarter And Year Ended March 31 2025 Declaration Of Dividend And Fixing Of Annual General Meeting1 day ago
Update On Letter Dated April 15 20258 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 19, 2025
Announcement under Regulation 30 (LODR)-AcquisitionApr 15, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 09, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementApr 07, 2025
Quarterly Update - Q4 FY2024-25Apr 02, 2025
Submission Of Information Under Regulation 30 Of SEBI (LODR) Regulations 2015Apr 02, 2025
Submission Of Information Under Regulation 30 Of SEBI (LODR) Regulations 2015Apr 01, 2025
Submission Of Information Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Receipt Of Cautionary LetterMar 28, 2025
Corporate Action-Board to consider DividendMar 28, 2025
Board Meeting Intimation for Considering Of Audited Financial Results For The Quarter/Financial Year Ending On 31St March 2025 And Dividend Mar 28, 2025
Closure of Trading WindowMar 28, 2025
Announcement under Regulation 30 (LODR)-Credit RatingMar 21, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 10, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSFeb 14, 2025
Submission Of Information Under Regulation 30 Of SEBI (LODR) Regulations 2015Feb 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 04, 2025
Submission Of Information Under Regulation 30 Of SEBI (LODR) Regulations 2015Feb 04, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 31, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 30, 2025
Integrated Filing (Financial)Jan 30, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJan 30, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 30, 2025
Submission Of Information Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 30, 2025
Unaudited Financial And Segment-Wise Results For The Quarter And Nine Months Ended December 31 2024Jan 30, 2025
Board Meeting Outcome for Unaudited Financial And Segment-Wise Results For The Quarter And Nine Months Ended December 31 2024Jan 30, 2025
Intimation Under Regulation 6 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 30, 2025
Announcement under Regulation 30 (LODR)-CessationJan 30, 2025
Appointment of Company Secretary and Compliance OfficerJan 30, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJan 30, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 13, 2025
Submission Of Information Under Regulation 30 Of SEBI (LODR) Regulations 2015Jan 13, 2025
Update On Previous Disclosure Dated October 30 2024Jan 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 10, 2025
Quarterly Update- Q3 FY2024-25Jan 03, 2025
Submission Of Information Under Regulation 30 Of SEBI (LODR) Regulations, 2015Dec 13, 2024
Submission Of Information Under Regulation 30 Of SEBI (LODR) Regulations, 2015.Dec 06, 2024

Technical Indicators

RSI(14)
Neutral
39.35
ATR(14)
Volatile
10.81
STOCH(9,6)
Neutral
35.96
STOCH RSI(14)
Neutral
28.03
MACD(12,26)
Bullish
0.21
ADX(14)
Weak Trend
15.92
UO(9)
Bearish
46.42
ROC(12)
Downtrend And Accelerating
-1.44
WillR(14)
Neutral
-77.25
Bearish
3
Neutral
5
Bullish
1

About Dabur

Dabur India Ltd is a leading FMCG company specializing in Ayurvedic and natural products. It operates in categories including hair care, oral care, health care, skin care, home care, and foods. The company has over 250 herbal and Ayurvedic products under brands like Dabur, Vatika, Hajmola, Real, and Fem. Dabur has 20 manufacturing facilities globally, with 12 in India. Its distribution network covers 6.9 million retail outlets in India and its products are available in over 120 countries. The company's portfolio includes health supplements, oral care products, juices, skin care items, and Ayurvedic medicines. Dabur has expanded through acquisitions and new product launches in various categories. It has also entered partnerships for global expansion and launched online sales platforms. The company focuses on innovation, introducing products like Ayurvedic tablets, herbal toothpastes, and immunity-boosting juices.
Website
https://www.dabur.com
Chairperson NameMohit Burman
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Technical Screeners
Price & Volume Screeners
Intraday Screeners
Fundamental Screeners
Candlestick Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2025 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.